FDA Inspection
Merck Sharp & Dohme LLCMerck Sharp & Dohme LLC – FDA Inspection, Mar 4, 2020
Record Details
This FDA Inspection record concerns Merck Sharp & Dohme LLC, with an inspection on March 4, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Merck Sharp & Dohme LLC
- Inspection Date
- March 4, 2020
- Product Type
- Biologics
View Company Profile
ID · b5288849-324e-4109-bcc7-d874ae63177e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1123248
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of Merck Sharp & Dohme LLC
18| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | Not classified | Baltimore District Office | |
| January 22, 2025 | Not classified | Baltimore District Office | |
| April 26, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 26, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Merck Sharp & Dohme LLC
- FDA Inspection 1296670 - 2025-11-21
- FDA Inspection 1258902 - 2025-01-22
- FDA Inspection 1210555 - 2023-04-26
- FDA Inspection 1094564 - 2019-06-28
- FDA Inspection 1073392 - 2018-10-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.